GO:0015220 choline transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015220 describes the molecular function that enables the transfer of choline across a membrane, a process essential for phospholipid synthesis and acetylcholine production.
• The high-affinity choline transporter CHT1 (SLC5A7) is the best-characterized protein carrying this activity, with a defined transmembrane topology and oligomeric structure.
• Choline transporters are critical in liver lipid metabolism, and their dysfunction is linked to metabolic dysfunction-associated steatohepatitis (MASH) and ferroptosis.
• Biallelic mutations in the choline/ethanolamine transporter FLVCR1 cause a pleiotropic disease spectrum ranging from adult neurodegeneration to severe developmental disorders.
• The osmoregulated choline transporter BetT provides structural insights into choline transport mechanisms and regulation.
• Studying GO:0015220 requires a combination of genetic, biochemical, and imaging approaches, with CRISPR-based models offering precise tools for functional dissection.
Description
Choline is an essential nutrient that serves as a precursor for the neurotransmitter acetylcholine and for phosphatidylcholine, a major component of cell membranes. The molecular function that mediates the movement of choline across biological membranes is classified as choline transmembrane transporter activity (GO:0015220). This activity is fundamental for maintaining choline homeostasis in various tissues, including the nervous system, liver, and airways. Researchers study this function to understand how cells acquire choline for lipid synthesis, how cholinergic signaling is sustained, and how defects in transport contribute to disease. The high-affinity choline transporter CHT1 (SLC5A7) is a prototypical member, and its transmembrane topology and oligomeric structure have been characterized. Other transporters, such as FLVCR1 and BetT, expand the functional and structural diversity of this GO term. Given its broad physiological importance, GO:0015220 is a focal point for investigations in neurobiology, hepatology, and developmental biology.
choline transmembrane transporter activity At A Glance
| GO ID | GO:0015220 |
|---|---|
| GO term | choline transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | amino acid/choline transmembrane transporter activity; choline permease activity |
| Major function | Enables the transfer of choline from one side of a membrane to the other, supporting phospholipid synthesis and acetylcholine production. |
| Representative genes | SLC5A7 (CHT1), FLVCR1, SLC44A1, SLC44A2, SLC44A3, SLC44A4, SLC44A5, and bacterial BetT. |
| Associated diseases | Neurodegeneration, developmental disorders, metabolic dysfunction-associated steatohepatitis (MASH), and airway cholinergic dysfunction. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, transport assays, electrophysiology, and structural biology. |
What Is GO:0015220?
According to the Gene Ontology, GO:0015220 (choline transmembrane transporter activity) is a molecular function that enables the transfer of choline from one side of a membrane to the other. Choline (2-hydroxyethyltrimethylammonium) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. This activity is synonymous with amino acid/choline transmembrane transporter activity and choline permease activity. It is distinct from other transporter activities by its specificity for choline and its role in moving this molecule across cellular membranes, which is essential for various metabolic and signaling pathways.
Why Is choline transmembrane transporter activity Important in Cell Biology?
Choline transmembrane transporter activity is vital because choline is required for the synthesis of phosphatidylcholine, a key membrane phospholipid, and for the production of acetylcholine, a neurotransmitter involved in muscle contraction, memory, and autonomic functions. Defects in choline transport can lead to impaired lipid metabolism, as seen in liver disease where choline deficiency contributes to steatosis and ferroptosis. In the nervous system, reduced choline uptake may compromise cholinergic signaling and contribute to neurodegeneration. Furthermore, choline transporters are implicated in developmental disorders and airway epithelial function. Understanding GO:0015220 therefore has broad implications for metabolic, neurological, and respiratory health.
• Essential for phosphatidylcholine synthesis and membrane integrity.
• Required for acetylcholine production and cholinergic neurotransmission.
• Dysfunction linked to metabolic dysfunction-associated steatohepatitis (MASH) and ferroptosis.
• Mutations in FLVCR1 cause a spectrum from adult neurodegeneration to severe developmental disorders.
• Choline transport in airways contributes to epithelial cholinergic system function.
• Target for understanding osmoregulation via bacterial BetT.
• Potential therapeutic target in liver disease and neurological disorders.
• Key to studying nutrient transport across membranes in health and disease.
What Happens During choline transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs choline from one side of the membrane.
Choline transporters exhibit high specificity for choline, which is recognized by a binding pocket formed by specific transmembrane helices. For CHT1, the transmembrane topology and oligomeric structure have been elucidated, revealing that the protein assembles into homo-oligomers to create a functional transport pathway. The binding affinity for choline is typically in the micromolar range, ensuring efficient uptake even at low extracellular concentrations.
Conformational change and translocation
In simple terms: The transporter changes shape to move choline across the membrane.
Upon binding, the transporter undergoes conformational changes that allow choline to be translocated from the extracellular side to the intracellular side. This process often involves alternating access mechanisms, where the substrate-binding site alternates between outward-facing and inward-facing states. Structural studies of the bacterial choline transporter BetT have provided insights into these conformational dynamics and the role of osmoregulation in modulating transport activity.
Release and resetting
In simple terms: Choline is released inside the cell, and the transporter resets for another round.
After translocation, choline is released into the cytoplasm, where it can be used for phospholipid synthesis or acetylcholine production. The transporter then returns to its original conformation to initiate another transport cycle. This cycle is energy-dependent in some transporters, such as CHT1, which couples choline uptake to sodium gradients. The efficiency of this cycle is critical for maintaining cellular choline homeostasis.
Key Genes Involved in GO:0015220 choline transmembrane transporter activity
The following genes encode proteins that exhibit choline transmembrane transporter activity or are directly involved in choline transport pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A7 (CHT1) | High-affinity choline transporter; mediates sodium-dependent choline uptake in cholinergic neurons. | Key target for studying cholinergic signaling and neurodegenerative diseases. |
| FLVCR1 | Choline and ethanolamine transporter; involved in heme and lipid metabolism. | Mutations cause neurodegeneration and developmental disorders. |
| SLC44A1 | Choline transporter-like protein 1; mediates choline transport in various tissues. | Regulates phospholipid synthesis and is implicated in cancer metabolism. |
| SLC44A2 | Choline transporter-like protein 2; expressed in inner ear and blood cells. | Potential role in hearing and immune function. |
| SLC44A3 | Choline transporter-like protein 3; expressed in colon and other tissues. | May contribute to choline uptake in epithelial cells. |
| SLC44A4 | Choline transporter-like protein 4; involved in choline transport in prostate and pancreas. | Linked to prostate cancer progression. |
| SLC44A5 | Choline transporter-like protein 5; expressed in testis and brain. | Function poorly characterized; potential role in male fertility. |
| BetT | Bacterial osmoregulated choline transporter; imports choline for osmoprotectant synthesis. | Model for structural and mechanistic studies of choline transport. |
| CHKA | Choline kinase alpha; phosphorylates choline in phosphatidylcholine synthesis. | Upregulated in cancer; target for imaging and therapy. |
| CHKB | Choline kinase beta; muscle-specific isoform. | Mutations cause muscular dystrophy. |
| PCYT1A | CTP:phosphocholine cytidylyltransferase alpha; rate-limiting enzyme in phosphatidylcholine synthesis. | Defects cause lipodystrophy and spastic paraplegia. |
| CEPT1 | Choline/ethanolamine phosphotransferase 1; final step in phosphatidylcholine synthesis. | Essential for membrane biogenesis. |
| ACHE | Acetylcholinesterase; degrades acetylcholine, indirectly affecting choline recycling. | Target for Alzheimer's disease drugs. |
| CHAT | Choline acetyltransferase; synthesizes acetylcholine from choline and acetyl-CoA. | Marker of cholinergic neurons. |
| OCT1 | Organic cation transporter 1; low-affinity choline transport in liver. | Contributes to hepatic choline uptake. |
| OCT2 | Organic cation transporter 2; transports choline in kidney. | Role in renal choline handling. |
| FATP5 | Fatty acid transport protein 5; may influence choline metabolism in liver. | Deficiency alleviates MASH via lipid remodeling. |
| SLC22A1 | Solute carrier family 22 member 1; polyspecific transporter including choline. | Genetic variants affect drug and choline transport. |
How Is choline transmembrane transporter activity Regulated?
Choline transmembrane transporter activity is regulated at multiple levels. The high-affinity choline transporter CHT1 is subject to regulation by protein kinase C and other signaling pathways that modulate its trafficking and activity. In the liver, choline transport is influenced by the osmoregulated transporter BetT in bacteria, which responds to osmotic stress. Additionally, the expression of choline transporter-like proteins (SLC44A1-5) is regulated by transcription factors and promoter methylation. In disease states such as MASH, altered lipid metabolism can affect choline transporter function and ferroptosis sensitivity. FLVCR1 activity is critical for heme and choline transport, and its mutations disrupt normal regulation.
choline transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLVCR1 | Neurodegeneration, developmental disorders | Knockout and knock-in mouse models; patient-derived iPSCs |
| SLC5A7 (CHT1) | Cholinergic deficiency, motor neuron disease | Conditional knockout mice; neuronal cell lines |
| FATP5 | MASH, ferroptosis | Liver-specific knockout mice; hepatocyte cell lines |
| SLC44A1 | Cancer metabolism, phospholipid synthesis | Overexpression and knockout cancer cell lines |
| CHKA | Cancer, muscular dystrophy | Xenograft models; CRISPR knockout |
Neurodegenerative disorders
Impaired choline transport can lead to reduced acetylcholine synthesis, contributing to cognitive decline in Alzheimer's disease and other neurodegenerative conditions. Mutations in FLVCR1 cause a spectrum of neurological phenotypes, including adult neurodegeneration and severe developmental disorders. CHT1 dysfunction has been linked to cholinergic deficits in motor neuron disease.
Metabolic dysfunction-associated steatohepatitis (MASH)
Choline deficiency is a well-known cause of hepatic steatosis. FATP5 deficiency alleviates MASH by remodeling hepatic lipid composition and suppressing ferroptosis, highlighting the interplay between choline transport and lipid metabolism. Choline transporters in the liver are essential for maintaining phosphatidylcholine levels and preventing lipid droplet accumulation.
Airway cholinergic dysfunction
The epithelial cholinergic system of the airways relies on choline transport for acetylcholine synthesis, which regulates mucus secretion and ciliary beat frequency. Dysregulation of choline transporters may contribute to chronic obstructive pulmonary disease and asthma.
From choline transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CHT1 affect cholinergic neurotransmission? | CRISPR knockout of SLC5A7 in neuronal cell lines or mice |
| How do point mutations in FLVCR1 alter choline transport? | CRISPR point mutation knock-in in HEK293 cells |
| Can overexpression of SLC44A1 rescue choline uptake in deficient cells? | CRISPR overexpression (CRISPRa) in knockout backgrounds |
| What is the subcellular localization of tagged choline transporters? | Knock-in of fluorescent tags (e.g., GFP) using CRISPR |
| Which genes regulate choline transporter expression? | CRISPR library screening with choline-dependent reporters |
| How does BetT mediate osmoregulation? | Bacterial knockout and complementation with mutant BetT |
How to Study the choline transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled choline uptake | Transport activity | Characterization of CHT1, FLVCR1, and SLC44A proteins |
| Patch-clamp electrophysiology | Ion currents coupled to transport | Stoichiometry and voltage dependence of choline transporters |
| Cryo-EM | 3D structure of transporter | Mechanistic insights into BetT and CHT1 |
| CRISPR knockout screening | Genes affecting choline uptake | Identification of novel regulators of choline transport |
| RNA-seq | Transcriptional changes | Expression profiling of choline transporters in disease models |
| Proteomics | Protein interactions and modifications | Identifying binding partners of choline transporters |
| Immunofluorescence | Subcellular localization | Trafficking of CHT1 and SLC44A proteins |
| Site-directed mutagenesis | Functional residues | Mapping the choline binding site |
Transport assays
Radiolabeled choline uptake assays are the gold standard for measuring choline transmembrane transporter activity. Cells expressing wild-type or mutant transporters are incubated with [3H]choline, and uptake is quantified by scintillation counting. This method has been used to characterize CHT1 and FLVCR1.
Electrophysiology
For electrogenic transporters, patch-clamp and two-electrode voltage clamp can measure transport currents. This approach has been applied to study the stoichiometry and voltage dependence of choline transporters.
Structural biology
X-ray crystallography and cryo-electron microscopy provide high-resolution structures of choline transporters, revealing substrate-binding sites and conformational changes. The structure of BetT has elucidated its osmoregulated mechanism.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate choline transport. Cells are cultured in choline-deficient media, and sgRNA libraries are used to find modifiers of cell survival or choline uptake.
How CRISPR Can Be Used to Study GO:0015220 choline transmembrane transporter activity
Knockout
CRISPR knockout of choline transporter genes (e.g., SLC5A7, FLVCR1) allows researchers to study loss-of-function phenotypes, such as reduced choline uptake, impaired acetylcholine synthesis, and altered lipid metabolism. Knockout cell lines and animal models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing disease-associated point mutations (e.g., in FLVCR1) via CRISPR base editing or homology-directed repair enables the study of specific amino acid changes on transporter function and trafficking. This approach can reveal genotype-phenotype correlations and test the efficacy of pharmacological chaperones.
Knock-in
Knock-in of epitope tags (e.g., HA, GFP) or reporter genes into endogenous choline transporter loci facilitates real-time imaging and biochemical purification. This method preserves native expression patterns and regulatory elements, providing physiologically relevant models.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of choline transporters can rescue loss-of-function phenotypes or create gain-of-function models. Overexpression studies help determine whether increased choline transport is sufficient to drive cellular processes like proliferation or acetylcholine production.
How EDITGENE Supports choline transmembrane transporter activity Research
Researchers studying choline transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in choline uptake, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for choline transmembrane transporter activity research.
Frequently Asked Questions About choline transmembrane transporter activity
What is choline transmembrane transporter activity?
It is a molecular function (GO:0015220) that enables the transfer of choline across a membrane, essential for phospholipid synthesis and acetylcholine production.
What genes are involved in choline transmembrane transporter activity?
Key genes include SLC5A7 (CHT1), FLVCR1, SLC44A1-5, and bacterial BetT.
How is choline transmembrane transporter activity regulated?
It is regulated by protein kinases, osmotic stress, and transcriptional mechanisms, with CHT1 trafficking modulated by PKC.
What diseases are associated with choline transporter dysfunction?
Neurodegeneration, developmental disorders, MASH, and airway cholinergic dysfunction.
What methods are used to study choline transporters?
Radiolabeled uptake assays, electrophysiology, cryo-EM, and CRISPR screening.
Can CRISPR be used to study choline transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting choline transporter function.
What is the role of CHT1 in cholinergic neurons?
CHT1 mediates high-affinity choline uptake, which is rate-limiting for acetylcholine synthesis.
How does FLVCR1 mutation cause disease?
Biallelic mutations in FLVCR1 impair choline and ethanolamine transport, leading to neurodegeneration and developmental defects.
What is the structural basis of choline transport?
Structures of BetT and CHT1 reveal alternating access mechanisms and oligomeric assembly.
How does choline transport relate to liver disease?
Choline deficiency contributes to steatosis; FATP5 deficiency alleviates MASH by remodeling lipids and suppressing ferroptosis.
Conclusion
Choline transmembrane transporter activity (GO:0015220) is a fundamental molecular function required for choline uptake, phospholipid synthesis, and acetylcholine production. Its dysregulation is implicated in a wide range of diseases, from neurodegeneration to metabolic liver disease. Advances in structural biology and CRISPR-based models continue to illuminate the mechanisms and therapeutic potential of choline transporters. EDITGENE provides essential tools to accelerate this research, enabling precise genetic manipulation and functional analysis.
References
- 1. Filali-Mouncef Y et al.. 2022. The ménage à trois of autophagy, lipid droplets and liver disease.. Autophagy 18(1):50-72 PMID: 33794741
- 2. Okuda T et al.. 2012. Transmembrane topology and oligomeric structure of the high-affinity choline transporter.. J Biol Chem 287(51):42826-34 PMID: 23132865
- 3. Haga T. 2014. Molecular properties of the high-affinity choline transporter CHT1.. J Biochem 156(4):181-94 PMID: 25073461
- 4. Yang T et al.. 2024. Structure and mechanism of the osmoregulated choline transporter BetT.. Sci Adv 10(33):eado6229 PMID: 39141726
- 5. Liu Y et al.. 2025. FATP5 deficiency alleviates MASH via remodeling hepatic lipid composition to suppress ferroptosis.. Free Radic Biol Med 240:170-182 PMID: 40840619
- 6. Yuan Z et al.. 2006. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1.. Physiol Genomics 26(1):76-90 PMID: 16609143
- 7. Calame DG et al.. 2024. Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a pleiotropic disease spectrum from adult neurodegeneration to severe developmental disorders.. medRxiv PMID: 38405817
- 8. Kummer W et al.. 2008. The epithelial cholinergic system of the airways.. Histochem Cell Biol 130(2):219-34 PMID: 18566825
